Page last updated: 2024-10-29

staurosporine aglycone and Rhabdomyosarcoma

staurosporine aglycone has been researched along with Rhabdomyosarcoma in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Rhabdomyosarcoma: A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (RHABDOMYOSARCOMA, ALVEOLAR), mainly in adolescents and young adults; embryonal (RHABDOMYOSARCOMA, EMBRYONAL), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rende, M1
Brizi, E1
Conner, J1
Treves, S1
Censier, K1
Provenzano, C1
Taglialatela, G1
Sanna, PP1
Donato, R1

Other Studies

1 other study available for staurosporine aglycone and Rhabdomyosarcoma

ArticleYear
Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2000, Volume: 18, Issue:8

    Topics: Animals; Antibodies; Carbazoles; Cell Differentiation; Cell Division; Dose-Response Relationship, Im

2000